05-18-2015 06:33 PM CET - Health & Medicine
Print

The 1,500th child supported by the Berlin Heart ventricular assist device has been transplanted

Press release from: Berlin Heart
1,500th child supported by the Berlin Heart ventricular assist device has been transplanted
1,500th child supported by the Berlin Heart ventricular assist device has been transplanted
The EXCOR® Pediatric ventricular assist device (VAD) has been implanted in more than 1,500 children worldwide to save their lives.

In June 2014 for the 1,500th time, the EXCOR® Pediatric device was implanted to save the life of a child: a 14-year-old boy from Hong Kong who was suffering from dilated cardiomyopathy since the age of four was supported with the life-saving device. Up to that point the teenager had been treated conservatively and was doing well. However his condition deteriorated at the beginning of the year so that in early June he was admitted to the Queen Mary Hospital in Hong Kong.
The LVAD implantation, to support the patient´s left ventricle, was performed by Dr. Timmy Wing-Kuk Au on the 20th of June 2014. Without the device, the boy would not have been able to wait for one of the scarce donor hearts. The recovery after the complex surgery went very well and the patient was able to do small exercises and walk around within the hospital grounds. In January, the boy´s biggest dream became true: a matching donor heart was found! The heart transplantation was performed by Dr. Au as well and the patient is now about to go home. Several patients were already treated with EXCOR® Pediatric by Dr. Au at the hospital in Hong Kong.
“We value the EXCOR® systems as it is efficient, very user friendly and it helps us to save our patients” Dr. Au summarizes the experience with the device.
This so-called artificial heart enables seriously ill children with heart defects to bridge the time until a suitable donor heart is found. It is the only system worldwide that is designed especially for the physiological needs of children.

This system was invented in Berlin and is used in children of all ages all over the world. The youngest patient that has been successfully supported with this device was just twelve days old.

„We are very happy to see that the 1500th patient could be successfully bridged to transplantation with our device. Our goal is to save critically ill patients worldwide with our systems” says Dr. Ares K. Menon, General Manager of the Berlin Heart GmbH.

About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The devices INCOR®, EXCOR® Adult and EXCOR® Pediatric can support failing hearts short-, mid- and long-term and therefore offer a life-saving therapy. Customers moreover benefit from clinical and technical support by Berlin Heart VAD specialists who are available 24/7. INCOR® and EXCOR® Adult are not FDA-approved, but widely used in Europe.


About EXCOR®
EXCOR® is a paracorporeal ventricular assist device for patients of all age groups, from newborns to adults. It is used for short-, mid- and long-term cardiac support and can support failing hearts for any duration from a couple of days to several months and years. Since the first implantation in 1988 EXCOR® has been implanted in more than 3,600 patients worldwide.

The Berlin Heart EXCOR® Pediatric Ventricular Assist Device (EXCOR® Pediatric) is approved for use by the FDA under a Humanitarian Device Exemption. All other products are unavailable in the US.

Berlin Heart GmbH
Wiesenweg 10
12247 Berlin

www.berlinheart.de

This release was published on openPR.
News-ID: 309864 • Views: 21162
More releases More releases

You can edit or delete your press release here: